0
Aurinia Pharmaceuticals Inc. Banner Image

Aurinia Pharmaceuticals Inc. has reached its limit for free report views

Work for Aurinia Pharmaceuticals Inc.? Upgrade Your Profile and unlock all your annual reports.

Aurinia Pharmaceuticals Inc.

  • Ticker AUP
    Exchange TSX More
  • Industry Biotechnology More
  • Sector Healthcare More
Aurinia Pharmaceuticals Inc. Logo Image
  • 51-200 Employees
  • Based in Victoria, British Columbia
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The company is currently developing voclosporin, an investigational drug, for the potential treatment of lupus nephritis and Dry Eye Syndrome. The company isMore headquartered in Victoria, British Columbia, its U.S. commercial hub in Rockville, MD, and focuses its development efforts globally.
Aurinia Pharmaceuticals Inc.

Most Recent Annual Report

Aurinia Pharmaceuticals Inc. MOST RECENT 2019 Annual Report

Report Locked. Aurinia Pharmaceuticals Inc. has reached its limit for free report views.

Older/Archived Annual Reports